Corbion, a global leader in sustainable specialty food ingredients, announces its latest awarded patent relating to the liquid suspension of algal biomass with a distinct DHA-rich omega-3 profile. This innovation builds on a unique suspension design of lysed algal cells in oil, enabling improved stability and performance in feed applications. The patent reflects the unique structure and functionality developed through Corbion’s algal fermentation platform and supports long-term differentiation in the market. This milestone reflects continued innovation and strengthens Corbion’s position in sustainable nutrition.

Corbion’s products such as AlgaPrime DHA LS translate this innovation to the market, delivering a consistent DHA-rich profile, ease of handling, and greater flexibility in feed formulations. The product is widely used in aquaculture feed, animal nutrition, and pet food.

Produced at scale through algal-fermentation, Corbion’s AlgaPrime products are fully traceable and reduce reliance on ocean resources, which is increasingly important for customers and end-markets.

With the recent grant in the United States, Corbion now holds enforceable patents across key markets, including Europe, several Latin American territories, China, Australia, and more. Additional territories are under review.

“This progress reflects our continued focus on developing meaningful innovations that bring concrete customer value,” said Tim Rutten, Head of Nutrition and Pharma Ingredients. “With broad protection in place that is still expanding, AlgaPrime DHA LS is well positioned to support our customers across aquaculture, animal nutrition, and pet food.”